tiprankstipranks
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market

Allergy Therapeutics (AGY) Income Statement

Compare
16 Followers

Allergy Therapeutics Income Statement

Last quarter (Q4 2023), Allergy Therapeutics's total revenue was £21.63M, a decrease of -10.16% from the same quarter last year. In Q4, Allergy Therapeutics's net income was £-24.57M. See Allergy Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
£ 55.20M£ 59.59M£ 72.77M£ 84.33M£ 78.20M
Gross Profit
£ 29.74M£ 32.69M£ 48.95M£ 61.80M£ 57.51M
Operating Expenses
£ 64.99M£ 67.54M£ 61.95M£ 59.16M£ 53.06M
Depreciation and Amortization
£ 4.32M£ 4.22M£ 4.17M£ 4.13M£ 3.91M
EBITDA
£ -30.74M£ -36.24M£ -8.69M£ 7.61M£ 11.69M
Operating Income
£ -35.26M£ -34.85M£ -13.00M£ 2.64M£ 4.46M
Other Income/Expenses
£ -3.91M£ -2.97M£ -1.15M£ -941.00K£ -872.00K
Pretax Income
£ -39.17M£ -42.62M£ -13.40M£ 3.09M£ 7.44M
Net Income
£ -40.22M£ -43.07M£ -13.78M£ 2.89M£ 7.06M
Per Share Metrics
Basic EPS
£ -0.01£ -0.06£ -0.02£ 0.00£ 0.01
Diluted EPS
£ -0.01£ -0.06£ -0.02£ 0.00£ 0.01
Weighted Average Shares Outstanding
3.74B 669.84M 643.02M 671.32M 672.19M
Weighted Average Shares Outstanding (Diluted)
3.74B 670.36M 642.99M 676.66M 673.49M
Currency in GBP

Allergy Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis